Resveratrol Regulates STIM1 to Inhibit Atherosclerosis

WU Zhi-xue; ZHANG Ren; LIN Rui-shan; XU Jin-wen; YAN Fu-man; LIU Hai-mei

doi:10.13422/j.cnki.syfjx.2017150148

Your Location：

Home >

Browse articles >

Resveratrol Regulates STIM1 to Inhibit Atherosclerosis

Updated：2024-01-04

Previous|Next

- Resveratrol Regulates STIM1 to Inhibit Atherosclerosis
- WU Zhi-xue , ZHANG Ren , LIN Rui-shan , XU Jin-wen , YAN Fu-man , LIU Hai-mei
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 23, Issue 15, Pages: 148-153(2017)
- Affiliations：
- Author bio：
- Funds：
- DOI： 10.13422/j.cnki.syfjx.2017150148
  CLC：
- Accepted：
Scan QR Code
DOI：
DOI：

Full Text(HTML)
References
Publication Info
Metrics

摘要

Abstract

关键词

Keywords

references

64

Views

62

Downloads

3

CSCD

Alert me when the article has been cited

Submit

Tools

BibTeXDownload
EndnoteDownload
RefMan Download
NoteExpressDownload
NoteFirstDownload

Publicity Resources

Related Articles

Effect of Resveratrol in Regulating TRPC1/STIM1-mediated SOCC to Inhibit Atherosclerosis

Mechanism of Wendan Tang Against Atherosclerosis by Regulating Ferroptosis Based on JAK2/STAT3 Signaling Pathway

Iron Homeostasis Imbalance Promotes Atherosclerosis and Therapeutic Mechanisms of Traditional Chinese Medicine

Mechanism of Huoxin Pills in Stabilizing Atherosclerotic Vulnerable Plaque Based on Network Pharmacology and Metabolomics

Differentiation and Treatment of Vulnerable Atherosclerotic Plaque Based on "Collateral Disease" Theory

Related Author

LIU Hai-mei

YAN Fu-man

ZHOU Le-quan

LIU Na

QIU Tingting

OUYANG Xiaoqiang

FANG Bangjiang

WANG Maohong

Related Institution

Jiangxi University of Chinese Medicine

The Affiliated Hospital of Jiangxi University of Chinese Medicine

Longhua Hospital Shanghai University of Traditional Chinese Medicine

School of Chinese Materia Medica，Guangzhou University of Chinese Medicine

Baiyunshan Pharmaceutical General Factory， Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd.

Chat